Trade Summary

6 days ago, Hudson Frederick M., serving as Dir at Supernus Pharmaceuticals, Inc. (SUPN), sold 5,369 shares at $50.61 per share, for a total transaction value of $271,725.00. Following this transaction, Hudson Frederick M. now holds 60,413 shares of SUPN.

This sale represents a 8.00% decrease in Hudson Frederick M.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 12, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 16, 2026, 4 days after the trade was made.

Supernus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.